These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11194083)
1. Cytological findings in cystic hypersecretory ductal carcinoma of the breast: a potential pitfall in mammary cytology. Schmitt F; Tani E Cytopathology; 2000 Dec; 11(6):513-9. PubMed ID: 11194083 [No Abstract] [Full Text] [Related]
2. Diagnosing invasive cystic hypersecretory duct carcinoma of the breast with fine needle aspiration cytology. A case report. Lee WY; Cheng L; Chang TW Acta Cytol; 1999; 43(2):273-6. PubMed ID: 10097724 [TBL] [Abstract][Full Text] [Related]
3. Cytologic characteristics of endocrine ductal carcinoma in situ of the breast. A case report. Yin H; Schinella R Acta Cytol; 2002; 46(5):873-6. PubMed ID: 12365222 [TBL] [Abstract][Full Text] [Related]
4. Fine needle aspiration cytology of pleomorphic lobular carcinoma of the breast. Duct carcinoma as a diagnostic pitfall. Dabbs DJ; Grenko RT; Silverman JF Acta Cytol; 1994; 38(6):923-6. PubMed ID: 7992580 [TBL] [Abstract][Full Text] [Related]
5. Mammary carcinoma with osteoclast-like giant cell: Fine needle aspiration and cytological diagnosis of a rare and misleading subtype of invasive ductal carcinoma. Bonsang B; Charles F; Conan-Charlet V; Guilbert S; Marcorelles P; Talagas M Cytopathology; 2019 May; 30(3):337-339. PubMed ID: 30549348 [No Abstract] [Full Text] [Related]
7. The role of fine-needle aspiration cytology and core biopsy in the diagnosis of proliferative and atypical breast lesions. Maygarden SJ Anat Pathol; 1997; 2():165-96. PubMed ID: 9575375 [No Abstract] [Full Text] [Related]
8. Fine-needle aspiration cytology of cystic hypersecretory ductal carcinoma in situ of the breast: a case report. Kratzer SS; Cramer HM; Reynolds HE; Seo IS; Canal DF Diagn Cytopathol; 1999 Mar; 20(3):160-3. PubMed ID: 10086241 [TBL] [Abstract][Full Text] [Related]
9. [Aspiration biopsy cytology for diagnosis of breast cancers]. Ikenaga M Nihon Rinsho; 2007 Jun; 65 Suppl 6():255-9. PubMed ID: 17682164 [No Abstract] [Full Text] [Related]
10. [Cystic hypersecretory carcinoma with microinvasive carcinoma and cystic hypersecretory hyperplasia of breast: report of a case]. Chen DB; Kan X Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):54-5. PubMed ID: 20388402 [No Abstract] [Full Text] [Related]
11. Cytohistomorphological grading of breast carcinoma with special reference to apoptotic rates and lymph node metastasis. Khan N; Rana F; Afroz N; Khan MA Indian J Pathol Microbiol; 2007 Jul; 50(3):613-8. PubMed ID: 17883162 [TBL] [Abstract][Full Text] [Related]
12. [Detection and treatment of ductal carcinoma of the breast]. Semiglazov VV; Tabagua TT; Matsko DE Vopr Onkol; 2011; 57(6):699-701. PubMed ID: 22416383 [No Abstract] [Full Text] [Related]
13. Fine needle aspiration and mammary secretion, cytology and core biopsy. Schenck U Anticancer Res; 1998; 18(3C):2151-3. PubMed ID: 9703774 [TBL] [Abstract][Full Text] [Related]
14. Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature. Sun J; Wang X; Wang C BMC Cancer; 2019 Jan; 19(1):31. PubMed ID: 30621638 [TBL] [Abstract][Full Text] [Related]
15. Breast procedures guided by magnetic resonance imaging. David J; Trop I; Lalonde L Can Assoc Radiol J; 2005 Dec; 56(5):309-18. PubMed ID: 16579025 [No Abstract] [Full Text] [Related]
16. [Comparison of touch imprint cytology of core needle biopsy and section histopathology in breast cancer diagnosis]. Zhang ZH; Zhao LL; Guo HQ; Zheng S; Zhang BL; Xu XZ; Pan QJ; Zhang BN Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):921-6. PubMed ID: 21223801 [TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic features of cystic hypersecretory lesion of the breast]. Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245 [TBL] [Abstract][Full Text] [Related]
18. Validity of needle core biopsy in the histological characterisation of mammary lesions. Cipolla C; Fricano S; Vieni S; Amato C; Napoli L; Graceffa G; Latteri S; Latteri MA Breast; 2006 Feb; 15(1):76-80. PubMed ID: 16473738 [TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine ductal carcinoma in situ of the breast: cytological features in 32 cases. Kawasaki T; Nakamura S; Sakamoto G; Kondo T; Tsunoda-Shimizu H; Ishii Y; Nakazawa T; Mochizuki K; Yamane T; Inoue M; Inoue S; Katoh R Cytopathology; 2011 Feb; 22(1):43-9. PubMed ID: 20236292 [TBL] [Abstract][Full Text] [Related]
20. No increased Ki67 expression in ductal carcinoma in situ associated with invasive breast cancer. Hoque A; Menter DG; Sahin AA; Sneige N; Lippman SM Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):153-4. PubMed ID: 11219775 [No Abstract] [Full Text] [Related] [Next] [New Search]